Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test ...

For the new cell-free DNA testing, a small amount of a person’s blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in ...

They have developed a blood-based method called RARE-seq that detects tumor-derived cell-free RNA with around 50 ... outperforming commonly used DNA-based approaches. RNA from vaccines and many ...

SeekIn has announced the clinical validation of its SeekInCare blood test, intended for the early identification of various ...

Estimation of population attributable fractions based on integrated global cancer incidence data, 1990-2021. Utilizing cancer community outreach and engagement to explain impact of age, income, ...

This so-called cell free DNA can be used to identify cancer at very early stages. In a breakthrough, scientists have now developed a method for detecting small amounts of cell-free RNA. When a cell is ...

For the new cell-free DNA testing, a small amount of a person’s blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient’s blood, ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare ®, a novel, non-invasive multi-omics blood test designed for the early ...

Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? Dear M.N.: When screening patients ...